OA09121A - Nouveau sel de strontium, son procédé de préparation et les compositions pharmaceutiques le renfermant. - Google Patents
Nouveau sel de strontium, son procédé de préparation et les compositions pharmaceutiques le renfermant.Info
- Publication number
- OA09121A OA09121A OA59600A OA59600A OA09121A OA 09121 A OA09121 A OA 09121A OA 59600 A OA59600 A OA 59600A OA 59600 A OA59600 A OA 59600A OA 09121 A OA09121 A OA 09121A
- Authority
- OA
- OAPI
- Prior art keywords
- pharmaceutical compositions
- preparation process
- compositions containing
- strontium salt
- new
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 159000000008 strontium salts Chemical class 0.000 title 1
- RVBQDKIUVOWMLH-UHFFFAOYSA-N 3-[5-carboxy-1-(carboxymethyl)pyrrol-3-yl]pentanedioic acid Chemical compound OC(=O)CC(CC(O)=O)C=1C=C(C(O)=O)N(CC(O)=O)C=1 RVBQDKIUVOWMLH-UHFFFAOYSA-N 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Light Receiving Elements (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8808729A FR2633619B1 (fr) | 1988-06-29 | 1988-06-29 | Nouveau sel de strontium, son procede de preparation et les compositions pharmaceutiques le renfermant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA09121A true OA09121A (fr) | 1991-10-31 |
Family
ID=9367847
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA59600A OA09121A (fr) | 1988-06-29 | 1989-06-28 | Nouveau sel de strontium, son procédé de préparation et les compositions pharmaceutiques le renfermant. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US4939164A (enExample) |
| EP (1) | EP0349432B1 (enExample) |
| JP (1) | JPH0248567A (enExample) |
| AT (1) | ATE81118T1 (enExample) |
| AU (1) | AU613297B2 (enExample) |
| CA (1) | CA1312333C (enExample) |
| DE (1) | DE68903059T2 (enExample) |
| DK (1) | DK325289A (enExample) |
| ES (1) | ES2044170T3 (enExample) |
| FR (1) | FR2633619B1 (enExample) |
| GR (1) | GR3006674T3 (enExample) |
| IE (1) | IE64112B1 (enExample) |
| NZ (1) | NZ229760A (enExample) |
| OA (1) | OA09121A (enExample) |
| PT (1) | PT91006B (enExample) |
| ZA (1) | ZA894945B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7404967B2 (en) * | 1994-12-21 | 2008-07-29 | Cosmederm, Inc. | Topical product formulations containing strontium for reducing skin irritation |
| FR2749759B1 (fr) * | 1996-06-17 | 1999-11-26 | Adir | Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose |
| DK2266584T3 (da) * | 2003-05-07 | 2013-01-02 | Osteologix As | Sammensætning med strontium og D-vitamin til profylakse og/eller behandling af brusk- og knogletilstande |
| JP4354984B2 (ja) * | 2003-05-07 | 2009-10-28 | オステオロジックス エイ／エス | 水溶性ストロンチウム塩を用いる軟骨／骨症状の治療 |
| WO2005082385A1 (en) * | 2004-02-26 | 2005-09-09 | Osteologix A/S | Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions |
| DK1768748T4 (da) | 2004-06-25 | 2019-06-11 | Mokwalo Spf S A | Sammensætninger omfattende strontium og vitamin D og anvendelser deraf |
| US7875627B2 (en) * | 2004-12-07 | 2011-01-25 | Abbott Laboratories | Thienopyridyl compounds that inhibit vanilloid receptor subtype 1 (VR1) and uses thereof |
| EP2530068A1 (en) | 2011-05-31 | 2012-12-05 | Lacer, S.A. | New strontium salts, synthesis and use thereof in the treatment of osteoporosis |
| EP3206803A1 (en) | 2014-10-14 | 2017-08-23 | Unilever NV | Spraying device |
| US10385560B2 (en) | 2014-10-14 | 2019-08-20 | Conopco, Inc. | Device for spraying an enclosure triggered by inclination of a rotatable lid |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2954384A (en) * | 1960-09-27 | Method for preparing kainic acid and its | ||
| DE3127275A1 (de) * | 1980-12-11 | 1983-01-27 | Leskovar, Peter, Dr.-Ing., 8000 München | "harnsteinaufloesende mittel" |
-
1988
- 1988-06-29 FR FR8808729A patent/FR2633619B1/fr not_active Expired - Lifetime
-
1989
- 1989-06-20 US US07/368,593 patent/US4939164A/en not_active Expired - Fee Related
- 1989-06-26 ZA ZA894945A patent/ZA894945B/xx unknown
- 1989-06-27 CA CA000604039A patent/CA1312333C/fr not_active Expired - Fee Related
- 1989-06-28 PT PT91006A patent/PT91006B/pt not_active IP Right Cessation
- 1989-06-28 OA OA59600A patent/OA09121A/xx unknown
- 1989-06-28 NZ NZ229760A patent/NZ229760A/en unknown
- 1989-06-28 IE IE209489A patent/IE64112B1/en not_active IP Right Cessation
- 1989-06-28 AU AU37092/89A patent/AU613297B2/en not_active Ceased
- 1989-06-29 EP EP89401861A patent/EP0349432B1/fr not_active Expired - Lifetime
- 1989-06-29 ES ES89401861T patent/ES2044170T3/es not_active Expired - Lifetime
- 1989-06-29 AT AT89401861T patent/ATE81118T1/de not_active IP Right Cessation
- 1989-06-29 DE DE8989401861T patent/DE68903059T2/de not_active Expired - Fee Related
- 1989-06-29 DK DK325289A patent/DK325289A/da not_active Application Discontinuation
- 1989-06-29 JP JP1168247A patent/JPH0248567A/ja active Granted
-
1992
- 1992-12-24 GR GR920403112T patent/GR3006674T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ229760A (en) | 1991-06-25 |
| AU613297B2 (en) | 1991-07-25 |
| EP0349432B1 (fr) | 1992-09-30 |
| PT91006A (pt) | 1989-12-29 |
| DK325289A (da) | 1989-12-30 |
| PT91006B (pt) | 1994-11-30 |
| DE68903059T2 (de) | 1993-04-29 |
| IE64112B1 (en) | 1995-07-12 |
| GR3006674T3 (enExample) | 1993-06-30 |
| ATE81118T1 (de) | 1992-10-15 |
| IE892094L (en) | 1989-12-29 |
| ZA894945B (en) | 1990-03-28 |
| DK325289D0 (da) | 1989-06-29 |
| CA1312333C (fr) | 1993-01-05 |
| FR2633619A1 (fr) | 1990-01-05 |
| JPH0248567A (ja) | 1990-02-19 |
| AU3709289A (en) | 1990-01-04 |
| ES2044170T3 (es) | 1994-01-01 |
| US4939164A (en) | 1990-07-03 |
| EP0349432A1 (fr) | 1990-01-03 |
| FR2633619B1 (fr) | 1991-02-08 |
| DE68903059D1 (de) | 1992-11-05 |
| JPH0587064B2 (enExample) | 1993-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA848369B (en) | Pharmaceutical compositions containing bilobalid for the treatment of neuropathies | |
| ES530046A0 (es) | Procedimiento para la obtencion de acidos quinoloncarboxilicos | |
| NZ228130A (en) | Therapeutic composition comprising fenofibrate and a solid surfactant which has been co-micronised; preparatory process | |
| AU590403B2 (en) | Pharmaceutical composition for the treatment of periodontal diseases | |
| FR2670491B1 (fr) | Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les renfermant. | |
| NO890259D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider. | |
| EP0376251A3 (en) | An anticoagulant substance obtained from urine | |
| SE7902742L (sv) | Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav | |
| OA09121A (fr) | Nouveau sel de strontium, son procédé de préparation et les compositions pharmaceutiques le renfermant. | |
| FR2618331B1 (fr) | Compositions pharmaceutiques utiles pour le traitement de l'uremie | |
| IL88971A (en) | Disubstituted pyridines, process and intermediates, their preparation and pharmaceutical compositions containing them | |
| NO810480L (no) | Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater | |
| ZA875847B (en) | Pharmaceutical compositions for the treatment of occlusive vascular diseases | |
| FR2614203B1 (fr) | Composition pharmaceutique pour le traitement des maladies de la peau et son procede de preparation. | |
| FR2600256B1 (fr) | Medicament et composition medicamenteuse pour le traitement des tumeurs ainsi que pour le traitement des maladies infectieuses dues aux virus | |
| DE3162277D1 (en) | N-(4-phenyl-2-thiazolyl)-oxamidic-acid-2-ethoxyethylester, process for its preparation and pharmaceutical compositions containing this compound | |
| HUT50633A (en) | Process for producing pharmaceutical compositions comprising 1,4-dihydropyridine derivatives | |
| YU262380A (en) | Process for obtaining piperidine derivatives of 4,5-dialkyl-3-hydroxy-pyrrol-2-carboxylic acid | |
| DK0538690T3 (da) | Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler | |
| SE8802323D0 (sv) | 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it | |
| HU895238D0 (en) | Process for the preparation of pharmaceutical composition suitable for the treatment of pyogenous skin diseases | |
| IL84012A0 (en) | Pharmaceutical composition for the treatment of high blood pressure | |
| HU895239D0 (en) | Process for the preparation of pharmaceutical compositions suitable for the treatment of skin diseases | |
| HU213268B (en) | Process for producing pharmaceutical composition for treating dermatological diseases | |
| GB8812620D0 (en) | Pharmaceutical composition for treatment of migraine &c |